DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Zhou H, Xu M, Qin P. et al.
A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP.
Blood 2015;
125: 1541-1547.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.